VRSK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Verisk Analytics Inc (VRSK) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company demonstrates solid fundamentals, including strong gross margins and a durable subscription franchise, the recent financial performance shows declining net income and EPS. Additionally, analysts have lowered price targets, and the stock is currently trading in a pre-market downtrend. The absence of strong trading signals and limited immediate catalysts suggest that holding off on a purchase may be prudent for now.
The MACD histogram is positive and expanding (3.157), indicating bullish momentum. However, RSI is at 77.799, which is neutral, and moving averages are converging, showing no clear trend. Key resistance levels are at R1: 199.912 and R2: 209.218, while support levels are at S1: 169.788 and S2: 160.482. The stock is currently trading at $202.64 in pre-market, down 2.01%.
Verisk Analytics launched a $1.5 billion accelerated share repurchase program, reflecting confidence in its cash flow and growth outlook.
The company has strong gross margins (59.6%) and a near-monopoly in the risk-assessment P&C insurance business.
Durable subscription franchise strength and growing adoption of AI-enabled solutions support long-term growth.
Analysts have broadly lowered price targets, citing decelerating growth and limited near-term catalysts.
Net income and EPS declined YoY in Q4 2025, indicating weaker profitability.
Pre-market price is down 2.01%, and broader market sentiment (S&P 500 down 0.83%) is negative.
The stock's short-term trend suggests a potential decline of -0.95% in the next week.
In Q4 2025, revenue increased by 5.87% YoY to $778.8 million, driven by subscription growth. However, net income dropped by 6.27% YoY to $197.2 million, and EPS decreased by 4.7% YoY to $1.42. Gross margin improved to 59.6%, up 2.26% YoY.
Analysts have lowered price targets across the board, with the average target now ranging from $205 to $230. While many analysts maintain positive ratings (Outperform/Overweight), they highlight concerns about decelerating growth, portfolio changes, and limited near-term catalysts. Some analysts remain optimistic about the company's long-term AI investments and subscription strength.
